Canine Comparative Oncology and Genomics Consortium Inc
Nonprofit profile at a glance
- EIN
- 383746822
- IRS 990-EZ coverage
- 2016–2023
- Forms available
- Form 990-EZ 2023
- Location
- Cary, NC, USA
- Phone
- 9194344399
- Rating confidence
- Limited
- Sector
- Research Institutes and/or Public Policy Analysis
Reported finances
- Revenue
- $-5,477
- Expenses
- $78,035
- Assets
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2023. Amounts in USD.
Leadership & pay
6 people listed
Executive titles in this filing
- DR MICHAEL KENT (PRESIDENT)
People named in this filing
- DR JAIME MODIANO (VICE PRESIDE)
- DR MATTHEW BREEN (TREASURER)
- DR MICHAEL KENT (PRESIDENT)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2023. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
To facilitate strategic partnerships and collaborations across a diversity of disciplines, focused on the problem of cancer in dogs.
What it reported doing in 2023
A repository of well-described tissues will provide opportunities not currently available to individual and institutional investigators interested in developing effective new treatments and prevention strategies for cancer
Operating model
- Revenue model
- Investment-supported. 100% of the money available for current operations came from recurring investment income.
- Distribution model
- Cannot be determined from the filing. The filing does not provide enough consistent spending detail to tell whether the nonprofit works directly or through others.
The verdict
- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.
Rating breakdown
- Financial Efficiency: NotEnoughData
- Transparency & Controls: 82
- Sustainability: 8
- Growth: 40
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: Limited
- Program expense ratio: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 51st percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: -1,524.8%; rating input score 2; 2nd percentile among comparable filings
- Total-asset coverage ratio: 0; rating input score 2; 2nd percentile among comparable filings
- Liabilities to assets ratio: Limited
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: 51.4% per year; rating input score 100; 92nd percentile among comparable filings
- Revenue growth: -88.5% per year; rating input score 0; 3rd percentile among comparable filings
- Asset growth: -17.7% per year; rating input score 0; 11th percentile among comparable filings
Details
- Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment
- Leadership: top reported pay $0 · 6 people listed
- Consistency: 4 of 4 current checks pass
- Schedules: 3 filed schedules
- Filing history: 8 filing years from 2016 to 2023
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Sustainability: Operating margin scored 2/100.
- High — Growth: Revenue growth scored 0/100.
- High — Sustainability: Total-asset coverage ratio scored 2/100.
- High — Growth: Asset growth scored 0/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.